These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3818966)

  • 1. A comparison of graphical nomogram methods with a computerized Bayesian analysis method in the interpretation of serum phenytoin concentrations.
    Chrystyn H; Morgan DH
    J Clin Hosp Pharm; 1986 Dec; 11(6):443-8. PubMed ID: 3818966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting phenytoin dosages using Bayesian feedback: a comparison with other methods.
    Yuen GJ; Taylor JW; Ludden TM; Murphy MJ
    Ther Drug Monit; 1983; 5(4):437-41. PubMed ID: 6659016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid i.v. loading with phenytoin with subsequent dose adaptation using non-steady-state serum levels and a Bayesian forecasting computer program to predict maintenance doses.
    Martinelli EF; Mühlebach SF
    J Clin Pharm Ther; 2003 Oct; 28(5):385-93. PubMed ID: 14632963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-point feedback control method for phenytoin dosage adjustment.
    Yukawa E; Higuchi S; Aoyama T
    J Pharm Pharmacol; 1991 Jul; 43(7):499-503. PubMed ID: 1682464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of methods for the prediction of phenytoin concentrations.
    Vázquez Rodríguez A; Santos Buelga D; Alonso González AC; Garcćia Sánchez MJ; Domínguez-Gil Hurlé A
    J Clin Pharm Ther; 1991 Feb; 16(1):55-62. PubMed ID: 2026669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A graphical nomogram method for predicting toxic concentrations of unbound phenytoin.
    Pospisil J; Pelclová D
    Int J Clin Pharmacol Ther; 1994 Mar; 32(3):122-5. PubMed ID: 8205372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing a mass-balance algorithm with a Bayesian regression analysis computer program for predicting serum phenytoin concentrations.
    Choy M; Winter ME
    Am J Health Syst Pharm; 1998 Nov; 55(22):2392-6. PubMed ID: 9825035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bayesian regression analysis of non-steady-state phenytoin concentrations: evaluation of predictive performance.
    Killilea T; Coleman R; Ludden T; Peck CC; Rose D
    Ther Drug Monit; 1989; 11(4):455-62. PubMed ID: 2741195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of single-point phenytoin dosage prediction techniques.
    Yukawa E; Higuchi S; Ohtsubo K; Aoyama T
    J Clin Pharm Ther; 1988 Aug; 13(4):293-305. PubMed ID: 3235480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a Bayesian regression-analysis computer program for predicting phenytoin concentration.
    Ludden TM; Beal SL; Peck CC; Godley PJ
    Clin Pharm; 1986 Jul; 5(7):580-5. PubMed ID: 3755661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a proposed method for phenytoin maintenance dose prediction following an intravenous loading dose.
    Crowley JJ; Koup JR; Cusack BJ; Ludden TM; Vestal RE
    Eur J Clin Pharmacol; 1987; 32(2):141-8. PubMed ID: 3582477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting serum lithium concentration using Bayesian method: a comparison with other methods.
    Higuchi S; Fukuoka R; Aoyama T; Horioka M
    J Pharmacobiodyn; 1988 Mar; 11(3):158-74. PubMed ID: 3411433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenytoin dosage predictions in paediatric patients.
    Yuen GJ; Latimer PT; Littlefield LC; Mackey RW
    Clin Pharmacokinet; 1989 Apr; 16(4):254-60. PubMed ID: 2721089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of six techniques for determining the Michaelis-Menten parameters relating phenytoin dose and steady-state serum concentrations.
    Mullen PW; Foster RW
    J Pharm Pharmacol; 1979 Feb; 31(2):100-4. PubMed ID: 33239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of eight phenytoin dosing methods in institutionalized patients.
    Flint N; Lopez LM; Robinson JD; Williams C; Salem RB
    Ther Drug Monit; 1985; 7(1):74-80. PubMed ID: 3992624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of a Bayesian forecasting technique with a new method for estimating phenytoin dose requirements.
    Bryson SM; Al-Lanqawi Y; Kelman AW; Whiting B
    Ther Drug Monit; 1988; 10(1):80-4. PubMed ID: 3376186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A method for prediction of phenytoin levels in the acute clinical setting.
    Scheyer RD; Mattson RH
    Comput Biomed Res; 1991 Dec; 24(6):564-75. PubMed ID: 1769232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical utility of a Bayesian dosing program for phenytoin.
    Privitera MD; Homan RW; Ludden TM; Peck CC; Vasko MR
    Ther Drug Monit; 1989; 11(3):285-94. PubMed ID: 2728087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nomogram for the prediction of unbound phenytoin concentrations in patients on a combined treatment of phenytoin and valproic acid.
    May TW; Rambeck B; Nothbaum N
    Eur Neurol; 1991; 31(1):57-60. PubMed ID: 2015840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenytoin clearances in a compliant population: description and application.
    Graves NM; Leppik IE; Termond E; Taylor JW
    Ther Drug Monit; 1986; 8(4):427-33. PubMed ID: 3824428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.